Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

6.79
-0.0100-0.15%
Post-market: 6.73-0.0600-0.88%19:30 EDT
Volume:869.89K
Turnover:5.85M
Market Cap:631.77M
PE:-1.57
High:6.80
Open:6.80
Low:6.63
Close:6.80
52wk High:29.30
52wk Low:3.76
Shares:93.04M
Float Shares:85.72M
Volume Ratio:0.56
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3264
EPS(LYR):-1.4051
ROE:-70.03%
ROA:-5.44%
PB:1.63
PE(LYR):-4.83

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Novavax, copper miners, Apple

Reuters
·
Aug 07

Hold Rating Maintained for Myriad Genetics Amid Mixed Performance and Strategic Challenges

TIPRANKS
·
Aug 06

Myriad Genetics (MYGN) Q2 Revenue Up 6%

Motley Fool
·
Aug 06

Myriad Genetics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 06

Myriad Genetics reports Q2 adjusted EPS 5c, consensus (1c)

TIPRANKS
·
Aug 06

Myriad Genetics backs FY25 adjusted EPS view (2c)-2c, consensus 1c

TIPRANKS
·
Aug 06

BRIEF-Myriad Genetics Q2 EPS USD -3.57

Reuters
·
Aug 06

Myriad Genetics Inc: Raised 2025 Revenue Guidance to a Range of $818 - $828 Million

THOMSON REUTERS
·
Aug 06

Myriad Genetics Inc: Reiterated Outlook FY Adjusted EPS Range of $-0.02 - $0.02

THOMSON REUTERS
·
Aug 06

Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum

GlobeNewswire
·
Aug 06

Myriad Genetics Secures $200 Million Credit Facility from OrbiMed to Fuel Growth Strategy

Reuters
·
Jul 31

Myriad Genetics Announces New $200 Million Credit Facility

THOMSON REUTERS
·
Jul 31

Myriad Genetics Inc - Facility Matures July 31, 2030, Interest Rate Sofr Plus 6.50%

THOMSON REUTERS
·
Jul 31

Myriad Genetics Inc. to Release Second Quarter 2025 Financial Results

Reuters
·
Jul 30

Insider Sellers Might Regret Selling Myriad Genetics Shares at a Lower Price Than Current Market Value

Simply Wall St.
·
Jul 22

Myriad Genetics Earns 2025 Great Place To Work Certification™

GlobeNewswire
·
Jul 15

Virginia Drosos Appointed to IFF Board of Directors, Joining Audit, Human Capital & Compensation, and Innovation Committees

Reuters
·
Jun 10

Myriad Genetics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 06

Balancing Optimism and Caution: Hold Rating for Myriad Genetics Amid Strategic Shifts and Uncertainties

TIPRANKS
·
Jun 05

Myriad Genetics Announces Launch of FirstGene Prenatal Screen in Large-Scale Clinical Study

Reuters
·
Jun 03